News About: Pharm. Industry
Foreign invested firms turn down KPMA's recent demand to vow the observance of fair trade code
Pharmaceutical industry sources say that there remains a serious disaccord between the Korea Pharmaceutical Manufacturers Association (KPMA) and foreign invested pharmaceutical firms, since the latter flatly rejected ...
US$5 million drug export target in Central America eyed
Business sources say that some countries in the Central America, which have suffer from business recession, is now in favor of drug markets into foreign competition by swifting their existing outlets from the United S...
KRICT to extend research exchange program with China
The Korea Research Institute of Chemical Technology (KRICT: President Kim Choong-sup) announced to extend a research exchange program with China in the fine chemical industry.
Dr. Kim took a trip to China on June 2...
KPTA to call for more investment-oriented government policies in R&D
In its meeting of Board of Directors on May 29, the Korean Pharmaceutical Manufacturers Association (KPMA) has recently criticized the government's drug-related policies to arbitrarily lower the insurance drug prices ...
Marine biological resources to be future bio-engineering bonanza.
The bio-engineering for marine products appears to be the most attractive and competitive technology in the BT market for the next generation. However, the current situation in this area shows very vulnerable technolo...
A sense of alienation prevailing in foreign invested pharmaceutical firms
Business sources say that there is the mounting discontent within foreign invested pharmaceutical firms over the government's drug-related policies, since they have a sense of alienation in the recent process of draft...
Product liability law emerging as a hot issue in health foods industry
Choi Sung-rak, manager of the Korea Food and Drug Administration, explained at a recent orientation session for 200 representatives of domestic health foods manufacturing firms his reports, citing various cases of pro...
KRPIA calls for reappraisal of medical insurance drug prices
The Korean Research-based Pharmaceutical Industry Association (KRPIA) has recently demanded the reappraisal of medical insurance drug prices through the previous review, according to its statement submitted to the Min...
Mounting discontent on new implementation of DMF and BGMP systems
With the impeding implementation of Drug Master File (DMF) and Bulk Good Manufacturing Practice (BGMP) on July 1, there are mounting discontents with these systems from many drug bulk importers, although the governmen...
Entertainment expenses limited at 50 thousand won level.
The KPMA drafted detailed fair trade provisions covering the entertainment expense limits including a food and beverage and gifts at 50 thousand won per a physician or pharmacist that usually provided in the event of ...
